Literature DB >> 21813266

Different hemodynamic response patterns in the prefrontal cortical sub-regions according to the clinical stages of psychosis.

Shinsuke Koike1, Ryu Takizawa, Yukika Nishimura, Yosuke Takano, Yoichiro Takayanagi, Masaru Kinou, Tsuyoshi Araki, Hirohiko Harima, Masato Fukuda, Yuji Okazaki, Kiyoto Kasai.   

Abstract

BACKGROUND: Symptomatic and functional outcomes in schizophrenia are associated with the duration of untreated psychosis. However, no candidate biomarkers have been adopted in clinical settings. Multichannel near-infrared spectroscopy (NIRS), which can easily and noninvasively measure hemodynamics over the prefrontal cortex, is a candidate instrument for clinical use. AIMS: We intended to explore prefrontal dysfunction among individuals at different clinical stages, including ultra-high-risk (UHR), first-episode psychosis (FEP), and chronic schizophrenia (ChSZ), compared to healthy subjects.
METHOD: Twenty-two UHR subjects, 27 patients with FEP, 38 patients with ChSZ, and 30 healthy subjects participated. We measured hemodynamic changes during a block-designed letter fluency task using multichannel NIRS instruments.
RESULTS: We found that the activations of the bilateral ventrolateral prefrontal cortex, and the fronto-polar and anterior parts of the temporal cortical regions in the UHR group were lower than those of the controls, but similar to those of the FEP and ChSZ groups. However, the activations in the bilateral dorsolateral prefrontal cortex regions decrease with advancing clinical stage.
CONCLUSIONS: To the best of our knowledge, this is the first study directly comparing differences in hemodynamic changes with respect to the 3 clinical stages of psychosis. Furthermore, this study also demonstrates different patterns of impairment according to the progression of clinical stages using NIRS instruments. NIRS measurements for UHR and FEP individuals may be candidate biomarkers for the early detection of the clinical stages of psychosis. Crown
Copyright © 2011. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813266     DOI: 10.1016/j.schres.2011.07.014

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  18 in total

1.  Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.

Authors:  Christin Schifani; Sina Hafizi; Huai-Hsuan Tseng; Cory Gerritsen; Miran Kenk; Alan A Wilson; Sylvain Houle; Pablo M Rusjan; Romina Mizrahi
Journal:  Schizophr Res       Date:  2018-11-06       Impact factor: 4.939

2.  Two-channel Near-infrared Spectroscopic Analysis of Association of Paranoia Symptoms with Prefrontal Activation.

Authors:  Kazuki Hirao
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-12-26       Impact factor: 2.582

3.  Reduced temporal activation during a verbal fluency test in clinical high risk of psychosis: a functional near-infrared spectroscopy-based study.

Authors:  Yanyan Wei; Xiaochen Tang; Tingyu Zhang; Wenjun Su; Lihua Xu; Huiru Cui; Zhenying Qian; Tianhong Zhang; Jijun Wang
Journal:  Gen Psychiatr       Date:  2022-04-28

Review 4.  A Narrative Review on Clinical Applications of fNIRS.

Authors:  Md Asadur Rahman; Abu Bakar Siddik; Tarun Kanti Ghosh; Farzana Khanam; Mohiuddin Ahmad
Journal:  J Digit Imaging       Date:  2020-09-28       Impact factor: 4.056

5.  Similar age-related decline in cortical activity over frontotemporal regions in schizophrenia: a multichannel near-infrared spectroscopy study.

Authors:  Po-Han Chou; Shinsuke Koike; Yukika Nishimura; Yoshihiro Satomura; Akihide Kinoshita; Ryu Takizawa; Kiyoto Kasai
Journal:  Schizophr Bull       Date:  2014-06-19       Impact factor: 9.306

6.  Differential patterns of blood oxygenation in the prefrontal cortex between patients with methamphetamine-induced psychosis and schizophrenia.

Authors:  Kazuhiko Yamamuro; Manabu Makinodan; Sohei Kimoto; Naoko Kishimoto; Tsubasa Morimoto; Michihiro Toritsuka; Kiwamu Matsuoka; Yoshihiro Takebayashi; Tomoyo Takata; Masato Takahashi; Yoshinori Tanimura; Yosuke Nishihata; Yasuhiro Matsuda; Toyosaku Ota; Hiroki Yoshino; Junzo Iida; Toshifumi Kishimoto
Journal:  Sci Rep       Date:  2015-07-16       Impact factor: 4.379

7.  A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study.

Authors:  S Koike; M Bundo; K Iwamoto; M Suga; H Kuwabara; Y Ohashi; K Shinoda; Y Takano; N Iwashiro; Y Satomura; T Nagai; T Natsubori; M Tada; H Yamasue; K Kasai
Journal:  Transl Psychiatry       Date:  2014-04-08       Impact factor: 6.222

Review 8.  Prediction and prevention of the first psychotic episode: new directions and opportunities.

Authors:  Sara Piras; Gianluca Casu; Maria Antonietta Casu; Alessandro Orrù; Stefania Ruiu; Antonio Pilleri; Gabriella Manca; Giorgio Marchese
Journal:  Ther Clin Risk Manag       Date:  2014-03-28       Impact factor: 2.423

Review 9.  Near-infrared spectroscopy in schizophrenia: a possible biomarker for predicting clinical outcome and treatment response.

Authors:  Shinsuke Koike; Yukika Nishimura; Ryu Takizawa; Noriaki Yahata; Kiyoto Kasai
Journal:  Front Psychiatry       Date:  2013-11-14       Impact factor: 4.157

10.  Associations between depressive symptoms and fronto-temporal activities during a verbal fluency task in patients with schizophrenia.

Authors:  Shenghong Pu; Kazuyuki Nakagome; Akihiko Miura; Masaaki Iwata; Izumi Nagata; Koichi Kaneko
Journal:  Sci Rep       Date:  2016-07-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.